南通醋酸化工股份有限公司 第一章 总则 第一条 为进一步完善南通醋酸化工股份有限公司（以下简称"公司"）法人治理 结构建设，为独立董事创造良好的工作环境，促进公司规范运行，根据《中华人 民共和国公司法》（以下简称"《公司法》"）《上市公司独立董事管理办法》（"以 下简称《独立董事办法》"）等法律、法规、规章、规范性文件及《南通醋酸化 工股份有限公司章程》（以下简称"《公司章程》"）的相关规定，制定本制度。 第二条 公司独立董事是指不在公司担任除董事外的其他职务，并与其所受聘的 公司及其主要股东、实际控制人不存在直接或间接利害关系，或者其他可能影响 其进行独立客观判断的关系的董事。 独立董事对公司及全体股东负有诚信与勤勉义务。独立董事须按照相关法 律、法规、规章、规范性文件及《公司章程》的要求，认真履行职责，维护公司 整体利益，尤其要关注中小股东的合法权益不受损害。 独立董事须独立履行职责，不受公司主要股东、实际控制人或者其他与公司 存在利害关系的单位或个人的影响。 第三条 公司董事会成员中应当包括不低于三分之一的独立董事，其中至少包括 一名会计专业人士，以会计专业人士身份被提名为独立董事候选人的，应具备较 丰 ...

证券代码：603968 证券简称：醋化股份 公告编号：临2023-050 南通醋酸化工股份有限公司 第八届董事会第十次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 南通醋酸化工股份有限公司（以下简称"公司"）第八届董事会第十次会议于 2023年12月12日以通讯表决的方式召开。本次会议通知于2023年12月9日以电子邮件 发出，本次会议应参与表决董事9人，实际参与表决董事9人。会议的召集和召开程 序符合《公司法》等相关法律法规及《公司章程》的有关规定，会议决议合法、有 效，会议由董事长庆九先生主持。 二、董事会会议审议情况 该议案尚需提交公司股东大会审议。 （三）审议并通过《关于改选董事会秘书的议案》》 同意聘任唐霞女士为公司第八届董事会董事会秘书。 公司独立董事对上述议案发表同意意见。 经表决：赞成9票，反对0票，弃权0票。 （四）审议并通过《关于修订<南通醋酸化工股份有限公司章程>的议案》 会议审议通过了如下议案： （一）审议并通过《关于对参股公司增资暨关联交易的议案》 具体内容详 ...

证券代码：603968 证券简称：醋化股份 公告编号：临2023-048 南通醋酸化工股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、担保情况概述 南通醋酸化工股份有限公司（以下简称"公司"）第八届董事会第五次会议 及公司 2022 年年度股东大会会议审议通过了《关于公司 2023 年度对下属子公司 担保计划的议案》，同意公司 2023 年度对全资子公司提供总额不超过人民币 12 亿元的担保（包含正在履行中的担保，其他币种可按当期汇率折算成人民币合并 计算），担保期限自 2022 年年度股东大会审议通过之日起至 2023 年年度股东大 会召开日内有效。 1、根据上述决议确定的担保限额，2023 年 12 月 7 日，公司与中国工商银 行股份有限公司南通港闸支行签订最高额保证合同，为主债权为自 2023 年 12 月 7 日至 2024 年 12 月 6 日期间（包括该期间的起始日和届满日），在人民币 35,000,000 元（大写：叁仟伍佰万元）（大小写不一致时，以大写为准）的 ...

2023 年第三季度报告 证券代码：603968 证券简称：醋化股份 南通醋酸化工股份有限公司 2023 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人庆九、主管会计工作负责人陶涛及会计机构负责人（会计主管人员）王玉娟保证 季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 1 / 10 单位：元 币种：人民币 项目 本报告期 本报告期 比上年同 期增减变 动幅度(%) 年初至报告期末 年初至报告 期末比上年 同期增减变 动幅度(%) 营业收入 810,877,246.87 -11.07 2,425,293,050.06 -12.77 归属于上市公司股东的净 利润 -23,637,771.98 -121.49 65,787,113.71 -79.63 归属于上 ...

二、主要产品的价格变动情况（不含税） 主要产品 2022 年 1-9 月 平均售价（元/吨） 2023 年 1-9 月 平均售价（元/吨） 前三季度同比 变动比率（%） 三季度环比变 动比率（%） 食品饲料添加剂 32,000.59 25,719.73 -19.63 -3.08 医药农药中间体 17,875.44 13,723.36 -23.23 -5.50 颜(染)料中间体 25,136.63 22,398.85 -10.89 -7.10 其他有机化合物 10,057.51 5,856.08 -41.77 -56.29 农药类产品 不适用 43,024.76 不适用 不适用 贸易收入 不适用 不适用 不适用 不适用 | | 平均进价（元/吨） | 平均进价（元/吨） | 变动比率（%） | 变动比率（%） | | --- | --- | --- | --- | --- | | 冰醋酸 | 4,382.77 | 3,110.39 | -29.03 | 20.24 | | 巴豆醛 | 14,982.44 | 14,640.68 | -2.28 | -6.45 | | 氢氧化钾 | 4,702.39 | 3,82 ...

证券代码：603968 证券简称：醋化股份 公告编号：临2023-046 南通醋酸化工股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 近日，各合伙人已完成第二期出资，具体出资情况如下： 一、基本情况 2022 年 7 月,南通醋酸化工股份有限公司（以下简称"公司"）公司召开第 七届董事会第十九次会议审议通过了《关于参与认购南通新兴产业基金有限合伙 份额的议案》，同意公司以现金出资 5000 万元人民币参与认购由南通紫琅私募基 金管理有限公司作为普通合伙人发起的基金有限合伙份额。具体内容详见公司 2022 年 7 月 15 日披露的《关于认购产业基金暨关联交易的公告》（公告编号： 临 2022-026）。 2022 年 8 月，南通新兴产业基金（有限合伙）已根据《证券投资基金法》 和《私募投资基金监督管理暂行办法》等法律法规的要求在中国证券投资基金业 协会完成私募投资基金备案，且各合伙人完成首次出资。具体内容详见公司 2023 年 8 月 26 日披露的《关于认购产业基金暨关联交易的进展公告》（公告编号：临 ...

Financial Performance - The company's operating revenue for the first half of 2023 was ¥1,614,415,803.19, a decrease of 13.60% compared to ¥1,868,591,328.76 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2023 was ¥89,424,885.69, down 58.03% from ¥213,058,850.30 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was ¥81,778,686.09, a decline of 60.75% compared to ¥208,378,740.09 in the same period last year[19]. - The net cash flow from operating activities was ¥80,322,527.87, which is a decrease of 54.42% from ¥176,227,310.39 in the previous year[19]. - Basic earnings per share for the first half of 2023 were ¥0.4272, down 59.00% from ¥1.0420 in the same period last year[20]. - The diluted earnings per share were ¥0.4268, a decrease of 59.04% compared to ¥1.0420 in the previous year[20]. - The weighted average return on net assets was 4.16%, a decrease of 0.44 percentage points from 4.60% in the previous year[20]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,580,853,797.03, an increase of 12.89% compared to ¥3,171,964,421.83 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 2.68% to ¥2,036,153,630.81 from ¥2,092,272,799.15 at the end of the previous year[19]. - Total liabilities reached RMB 1,457,455,685.72, up from RMB 1,079,691,622.68, which is an increase of about 35%[121]. - Long-term borrowings increased to RMB 320,306,485.93 from RMB 200,000,000.00, reflecting a growth of 60.2%[121]. Cash Flow and Investment - The company reported a net cash outflow from investment activities of ¥62,490,896.63, a significant decline of 145.24% from a net inflow of ¥138,122,232.40 last year[32]. - The net cash flow from investing activities was -44,575,617.59 RMB, contrasting with a positive 215,056,995.65 RMB in the first half of 2022[136]. - Cash inflow from investing activities was 305,170,760.22 RMB, down 55.7% from 688,833,271.02 RMB year-on-year[136]. Research and Development - Research and development expenses increased by 7.97% to ¥46,326,753.33 compared to ¥42,908,942.97 in the previous year[32]. - Research and development expenses for the first half of 2023 were CNY 46,326,753.33, up from CNY 42,908,942.97 in the same period of 2022[126]. Environmental Compliance - The company emphasizes environmental protection and has obtained ISO 14001:2004 certification for its environmental management system[49]. - The company has established a comprehensive internal governance system to manage environmental protection and ensure compliance with increasing regulatory standards[49]. - The company has implemented comprehensive pollution control measures, achieving compliance with air pollutant discharge standards, including the use of closed and automated equipment to reduce emissions[72]. - The company has established a wastewater treatment facility with a capacity of 5000 tons per day, utilizing UASB and aerobic biochemical treatment processes, ensuring compliance with national wastewater discharge standards[70]. Shareholder Dynamics - The total number of ordinary shareholders as of the end of the reporting period is 12,959[108]. - The top ten shareholders hold a total of 100,000,000 shares, with the largest shareholder, Gu Qingquan, owning 18,459,700 shares, representing 8.82% of the total shares[110]. - The company reported a decrease in shareholding for several key shareholders, including a reduction of 1,639,900 shares by Gu Qingquan and 1,101,400 shares by Chairman Qing Jiu[112]. Corporate Governance - The company established a governance structure including a board of directors and various committees to enhance strategic decision-making[155]. - The company has engaged in daily related party transactions, adhering to fair pricing principles[95]. Risk Management - The company faces risks related to public misunderstanding of food additives, which could impact product sales despite their safety[46]. - The company is exposed to market risks due to uncertainties in the food and pharmaceutical sectors, despite the generally inelastic demand for its products[52]. Strategic Focus - The company is focusing on "green and low-carbon" research in response to national policies on carbon neutrality and energy consumption control[28]. - The company is implementing a centralized procurement model to enhance operational efficiency and cost management[25].

南通醋酸化工股份有限公司（以下简称"公司"）已于 2023 年 4 月 18 日在 《中国证券报》、《上海证券报》、《证券日报》以及上海证券交易所网站 （http://www.sse.com.cn）披露了公司《2022 年年度报告》。为了便于广大投 资者全面、深入了解公司 2022 年度经营成果及财务状况，公司计划于 2023 年 6 月 29 日下午 15:00 至 16:00 召开"2022 年度业绩说明会"，就投资者普遍关注 的问题进行回答。 一、说明会类型 会议召开时间：2023 年 6 月 29 日（星期四）下午 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 6 月 20 日(星期二)至 6 月 28 日(星期三)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目进行提问，公司 将在说明会上就投资者普遍关注的问题进行回答。 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟 ...

2023 年第一季度报告 证券代码：603968 证券简称：醋化股份 南通醋酸化工股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 项目 本报告期 本报告期比上年同期 增减变动幅度(%) 营业收入 794,029,079.57 -13.94 归属于上市公司股东的净利润 48,978,723.04 -46.06 归属于上市公司股东的扣除非经常性损益的净利润 47,530,582.02 -42.95 经营活动产生的现金流量净额 -143,645,148.05 -266.70 基本每股收益（元/股） 0.2395 -46.07 稀释每股收益（元/股） 0.2393 -46.12 加权平均净资产收益率（%） 2.31 减少 2.64 个百分点 本报告期 ...

Financial Performance - The company's operating revenue for 2022 was approximately CNY 3.59 billion, representing a year-on-year increase of 19.71% compared to CNY 2.99 billion in 2021[22]. - The net profit attributable to shareholders for 2022 was approximately CNY 401.49 million, a significant increase of 130.67% from CNY 174.06 million in 2021[22]. - The basic earnings per share for 2022 was CNY 1.9635, up 130.67% from CNY 0.8512 in 2021[23]. - The weighted average return on equity for 2022 was 20.68%, an increase of 10.58 percentage points compared to 10.10% in 2021[23]. - The net cash flow from operating activities for 2022 was approximately CNY 326.23 million, a 97.97% increase from CNY 164.79 million in 2021[22]. - Total assets at the end of 2022 were approximately CNY 3.17 billion, reflecting a year-on-year increase of 13.94% from CNY 2.78 billion in 2021[22]. - The company's net assets attributable to shareholders at the end of 2022 were approximately CNY 2.09 billion, an increase of 16.90% from CNY 1.79 billion in 2021[22]. - The company reported a net profit excluding non-recurring gains and losses of approximately CNY 397.80 million, which is a 210.02% increase from CNY 128.31 million in 2021[22]. Dividend Distribution - The company plans to distribute a cash dividend of CNY 8 per 10 shares, totaling approximately CNY 167.45 million[5]. - The company distributed a cash dividend of 5 yuan (including tax) for every 10 shares, totaling 102.24 million yuan, which was implemented in June 2022[161]. - The company plans to distribute a cash dividend of 8 RMB per 10 shares, totaling approximately 167.45 million RMB, which represents 41.71% of the net profit attributable to ordinary shareholders in the consolidated financial statements[166]. Revenue Growth - In 2022, the company achieved a total revenue of CNY 3.59 billion, representing a year-on-year growth of 19.71%[40]. - The company reported a total annual revenue increase driven by higher average product prices and a decline in raw material costs, resulting in a substantial growth in operating performance compared to the previous year[31]. - The revenue from pharmaceutical and pesticide intermediates reached approximately ¥831.09 million, an increase of 6.88 percentage points compared to the previous year[44]. - The total revenue from direct sales was approximately ¥2.42 billion, with a gross profit margin of 19.49%, which increased by 7.92 percentage points compared to the previous year[44]. Research and Development - Research and development expenses increased by 17.84% to CNY 104 million, reflecting the company's commitment to innovation[43]. - The company holds 46 invention patents and 6 utility models, showcasing its strong technological advantages in the fine chemical industry[34]. - The company has implemented a talent development strategy that combines internal training and external recruitment to enhance its R&D capabilities[88]. - The company is focusing on clean production technologies for acetic acid and pyridine derivatives as part of its R&D efforts[87]. Environmental Management - Environmental protection is a priority for the company, which has established a standardized environmental management system and achieved ISO 14001:2004 certification[125]. - The company has implemented a series of environmental protection measures to manage wastewater, waste gas, and solid waste[182]. - The company has a comprehensive emergency response plan for environmental incidents, which includes 14 chapters detailing risk assessment, emergency response organization, and preventive measures[189]. - The company has engaged professional environmental companies for the treatment of general industrial waste, ensuring compliance with environmental regulations[184]. Corporate Governance - The company has established a sound corporate governance structure, ensuring compliance with relevant laws and regulations, with no significant discrepancies reported[130]. - The company has a clear decision-making mechanism that protects the interests of all shareholders, particularly minority shareholders[130]. - The company has maintained a stable board of directors with no significant changes in key management personnel during the reporting period[134]. - The company has established specialized committees, including an audit committee and a remuneration and assessment committee, to enhance governance[149]. Market Position and Strategy - The company is focusing on the construction of four major bases in food science, life science, material science, and high-end specialty chemicals to achieve high-quality development[32]. - The company is involved in various national and provincial technology projects, enhancing its innovation capabilities[79]. - The company aims to align with national strategies focusing on innovation, coordination, green development, and high-quality growth, leveraging over 60 years of industry experience[74]. - The company operates in a weakly cyclical industry, specifically in food additives and pharmaceutical pesticide intermediates, which are less affected by economic cycles[78]. Safety Management - The company implemented a dual prevention mechanism for safety risk management, collaborating with Changzhou Xinyang Technology Service Co., Ltd. to enhance digital safety risk control[63]. - The company conducted a comprehensive self-inspection of major safety hazards, with all identified issues rectified and closed-looped[66]. - The company has established a "3+X" safety management system, aiming for first-level safety standardization in hazardous chemical enterprises[64]. Talent and Workforce - The company employed 132 R&D personnel, making up 17.78% of the total workforce[52]. - The company has a total of 904 employees, with 671 in the parent company and 298 in major subsidiaries[156]. - The company has a training plan focusing on internal lecturer development and skills training for employees[159]. Future Outlook - The company is focusing on new product development and technological advancements to enhance market competitiveness[136]. - Market expansion strategies are being evaluated, although no specific regions or markets have been identified yet[136]. - The company plans to enhance its digital marketing efforts, increasing the budget by G% to drive user acquisition[138].